Skip to main content

Table 4 The results of primary and secondary patency rates for different lesions in non-diabetes group

From: Efficacy of endoluminal interventional therapy in diabetic peripheral arterial occlusive disease: a retrospective trial

   6 months 12 months 24 months 36 months
iliac lesions (n = 32) primary patency rate 96.9% ± 3.1% 86.5% ± 6.3% 77.5% ± 8.3% 71.1% ± 9.8%
  secondary patency rate 100% ± 0% 100% ± 0% 90.3% ± 6.5% 83% ± 5.7%
femoral lesions primary patency rate 93.4% ± 3.2% 80.9% ± 5.2% 73.9% ± 6.1% 52.8% ± 8.6%
(n = 61) secondary patency rate 95.1% ± 2.8% 93.3% ± 3.2% 88.7% ± 4.4% 83% ± 5.7%
popliteal primary patency rate 82.6% ± 7.9% 63.2% ± 10.4% 47.7% ± 11.1% 39.8% ± 11.7%
lesions
(n = 23)
secondary patency rate 100% ± 0% 90.5% ± 6.4% 75.9% ± 9.4% 56.9% ± 11.8%
tibial primary patency rate 73.7% ± 10.1% 55.3% ± 11.9% 34.5% ± 12% 34.5% ± 12%
lesions
(n = 19)
secondary patency rate 89.5% ± 7% 71.6% ± 10.8% 57.8% ± 12.4% 38.6% ± 13.9%